Register Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Buy
1,219
+4
+0.3% +$4.09K 0.45% 69
2026
Q1
$1.12M Buy
1,215
+13
+1% +$13.2K 0.41% 73
2025
Q4
$1.29M Buy
1,202
+2
+0.2% +$1.91K 0.5% 61
2025
Q3
$916K Sell
1,200
-11
-0.9% -$8.19K 0.36% 75
2025
Q2
$944K Buy
1,211
+221
+22% +$172K 0.41% 65
2025
Q1
$818K Sell
990
-200
-17% -$166K 0.43% 65
2024
Q4
$919K Buy
1,190
+20
+2% +$16.6K 0.46% 57
2024
Q3
$1.04M Buy
1,170
+12
+1% +$10.8K 0.53% 53
2024
Q2
$1.05M Buy
1,158
+91
+9% +$72.8K 0.53% 49
2024
Q1
$830K Buy
1,067
+61
+6% +$43.4K 0.43% 64
2023
Q4
$586K Buy
1,006
+515
+105% +$301K 0.39% 70
2023
Q3
$264K Buy
491
+4
+0.8% +$2.06K 0.19% 111
2023
Q2
$228K Hold
487
0.16% 124
2023
Q1
$167K Hold
487
0.13% 139
2022
Q4
$178K Buy
+487
New +$173K 0.11% 169

Other funds holding LLY

Register Financial Advisors's LLY Position: Q2 2026 in Review

Register Financial Advisors increased its Eli Lilly (LLY) stake by 0.33% in Q2 2026, buying an estimated $4.09K and bringing the position to 1,219 shares worth $1.46M. The position accounts for 0.45% of the portfolio, ranked #69.

Register Financial Advisors first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,842 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Register Financial Advisors held 1,219 shares of Eli Lilly worth $1.46M as of Q2 2026.
  • Register Financial Advisors bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
  • Eli Lilly made up 0.45% of Register Financial Advisors's portfolio in Q2 2026, its #69 holding.
  • Register Financial Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,842 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Register Financial Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.